Status:
RECRUITING
Prostate Cancer Patients Treated With Alternative Radiation Oncology Strategies
Lead Sponsor:
University Hospital Heidelberg
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
As the most common male carcinoma, prostate cancer is a major tumor entity in oncology. In addition to definitive radiotherapy, surgical procedure is considered to be an oncologically equivalent thera...
Eligibility Criteria
Inclusion
- histology-proven prostate cancer with Gleason Score and PSA-value;
- indication for prostate bed irradiation (adjuvant/ salvage) after prostatectomy;
- Karnofsky-Index ≥ 70%
- age ≥ 18 years
Exclusion
- androgen deprivation therapy
- lymphatic spread
- macroscopic tumor/ R2
- stage IV (M1)
- previous irradiation
Key Trial Info
Start Date :
September 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2029
Estimated Enrollment :
897 Patients enrolled
Trial Details
Trial ID
NCT04083937
Start Date
September 12 2018
End Date
January 1 2029
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Heidelberg
Heidelberg, Germany, 69120